Harbour Lab Tour: Attendees stepped inside UT Southwestern's lab to meet the scientists studying ocular melanoma. HEPZATO Demonstration: Drs. Chandrasekaran and Shannon led a closer look at liver-directed treatment for metastatic disease. Expert Medical Program: Sessions covered surveillance, biomarkers, adjuvant therapy, treatment sequencing, [...]
Researchers identified BAP1 gene abnormalities as a strong predictor of metastatic uveal melanoma. Combining BAP1 changes with chromosome 1 alterations improved the accuracy of metastasis risk prediction. The new classification system successfully separated patients into four distinct metastatic risk groups. Genetic changes linked [...]
Read full article: Delcath Systems, Inc. recently announced the publication of important subgroup analyses from its Phase 3 FOCUS study evaluating melphalan delivered via a Hepatic Delivery System in patients with unresectable metastatic uveal melanoma (mUM). Published in the Journal of [...]
Read full article: Metastatic uveal melanoma remains one of the most serious challenges facing patients diagnosed with this rare but aggressive eye cancer. While local control of the primary tumor is often successful, up to 50% of patients will eventually develop [...]
Read full article: Napa, California – November 1, 2025– The nonprofit organization A Cure In Sight™ (ACIS) is proud to announce the 2026 Swing for Sight fundraiser, to take place at Silverado Resort & Spa, 1600 Atlas Peak Road, Napa, California. All [...]
Read full article: Advances in topical immunotherapy are opening new possibilities for managing rare and challenging eye cancers, including ocular melanoma–related conditions. A recently published case series explores the use of compounded imiquimod 5% ointment as a potential treatment for diffuse [...]
Read full article: This week’s ophthalmic research highlights two critically important—and often overlooked—factors affecting patients with serious eye disease, including ocular melanoma: visual function in daily living environments and access to specialized ocular oncology care. Together, these findings underscore how both [...]
Read full article: Stories like Melanie Wightman’s illuminate the emotional, physical, and lifelong challenges faced by people diagnosed with ocular melanoma, a rare but aggressive eye cancer that too often goes undetected until it is advanced. Her journey—beginning with an unexpected [...]
Read full article: In a significant step forward for the ocular melanoma community, TrilliumBiO and Oncobit have announced a new partnership that promises to transform the way uveal melanoma is monitored and managed in the United States. For patients, caregivers, and [...]
Raleigh, ND — November 1, 2025 Media Contact: Name: Melody Burchett Email: melody@acureinsight.org Phone: 99-8855264 Website: https://acureinsight.org Download the App Raleigh NC — November 1, 2025 — A Cure In Sight (ACIS) is proud to announce the launch of the ACIS App, a brand-new mobile resource [...]
